BLCONYSEOphthalmic GoodsFiscal year ends December 31
Bausch & Lomb Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.61+0.12 (+0.73%)
Close on Oct 19, 2026
- Market cap
- $5.93B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.61 (+10.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Bausch & Lomb Corp grew revenue 8.9% to $5.32B over the twelve months to Jun 30, 2026. Operating income rose 797.2% to $323.00M, moving the operating margin from 0.7% to 6.1%. Free cash flow was $137.00M.
Revenue
$5.32B
+8.9% vs. a year earlier
Operating income
$323.00M
+797.2% vs. a year earlier
Free cash flow
$137.00M
TTM Q2 2026
EPS, diluted
-$0.48
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.93B
- P/E ratio
- –
- Price to sales
- 1.11
- Price to book
- 0.93
- Dividend yield
- –
- Free cash flow yield
- 2.31%
Fundamentals
- Revenue
- $5.32B
- Net income
- -$171.00M
- EPS, diluted
- -$0.48
- Free cash flow
- $137.00M
- Book value per share
- $17.85
- Diluted shares
- 357M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$5.32B+8.9% YoY
Operating income
$323.00M+797.2% YoY
Net income
-$171.00M
EPS, diluted
-$0.48
Free cash flow
$137.00M
Reported periodTrailing twelve months